首页> 外国专利> Antibiotic pa-39504-X1 from streptomyces sp. atcc 31569

Antibiotic pa-39504-X1 from streptomyces sp. atcc 31569

机译:来自链霉菌sp。的抗生素pa-39504-X1。 atcc 31569

摘要

Antibiotic PA-39504-X1 of formula (I) and its salts with bases are new: Cpd. (I) is obtd. by aerobic cultivation of Streptomyces argenteolus ATCC 31589 or Streptomyces tokunonensis ATCC 31569 in a nutrient medium, esp. at 20-40 deg.C for 20-80 hrs. The isolated (I) as Me ester has a mass spectrum m/e of 341 and characterising circular dichroism, u.v. absorption and n.m.r. spectra. Cpds. (I) is a broad-spectrum antibacterial and beta-lactamase inhibitor. It is suitable for use as a therapeutic agent, a veterinary agent and a sterilising agent, and it can be used as a beta-lactamase inhibitor in synergistic combination with a penicillin, cephalosporin or other beta-lactam antibiotic. Dose is 0.1-30 g daily subcutaneously.
机译:式(I)的抗生素PA-39504-X1及其与碱的盐是新的:Cpd。 (I)太过分了。通过在营养培养基,特别是有氧培养基中对有氧链霉菌ATCC 31589或德链链霉菌ATCC 31569进行有氧培养。在20-40摄氏度下20-80小时。分离出的作为甲酸酯的(I)的质谱m / e为341,表征圆二色性,u.v。吸收和n.m.r.光谱。 Cpds。 (I)是一种广谱抗菌和β-内酰胺酶抑制剂。它适合用作治疗剂,兽药和灭菌剂,并且可以与青霉素,头孢菌素或其他β-内酰胺抗生素协同组合用作β-内酰胺酶抑制剂。皮下剂量为每日0.1-30 g。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号